Concepedia

Author

Carlos L. Morais

Johns Hopkins University

Also Known As

C. L. Morais, Carlos L Morais, Carlos L. Morais

47

Publications

815

Citations

11

H-Index

16

Concepts

All Affiliations

Johns Hopkins UniversityJohns Hopkins MedicineThe University of Texas MD Anderson Cancer CenterUniversity of WashingtonCleveland Clinic
CL

About

Carlos L. Morais is an author at Johns Hopkins University specializing in medicine, urology, and pathology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

6

6

377

2

Public Health

1

1

24

3

Epidemiology

1

1

24

4

Hospital Medicine

1

1

24

5

Medical Laboratory Science

1

1

24

Carlos L. Morais

×

11

Publications

804

Citations

11

H-Index

YearCitations

A Prospective Investigation of PTEN Loss and ERG Expression in Lethal Prostate Cancer

Thomas U. Ahearn, Andreas Pettersson, Ericka M. Ebot,

JNCI Journal of the National Cancer Institute

2015

192

Utility of PTEN and ERG Immunostaining for Distinguishing High-grade PIN From Intraductal Carcinoma of the Prostate on Needle Biopsy

Carlos L. Morais, Jeong Han, Jennifer Gordetsky,

The American Journal of Surgical Pathology

2014

118

Analytic validation of a clinical-grade PTEN immunohistochemistry assay in prostate cancer by comparison with PTEN FISH

Tamara L. Lotan, Wei Wei, Olga Ludkovski,

Modern Pathology

2016

89

Prevalence and Prognostic Significance of PTEN Loss in African-American and European-American Men Undergoing Radical Prostatectomy

Jeffrey J. Tosoian, Fawaz Almutairi, Carlos L. Morais,

European Urology

2016

82

PTEN Loss as Determined by Clinical-grade Immunohistochemistry Assay Is Associated with Worse Recurrence-free Survival in Prostate Cancer

Tamara L. Lotan, Wei Wei, Carlos L. Morais,

European Urology Focus

2015

73

Cyclin D1 Loss Distinguishes Prostatic Small-Cell Carcinoma from Most Prostatic Adenocarcinomas

Harrison Tsai, Carlos L. Morais, Mohammed Alshalalfa,

Clinical Cancer Research

2015

67

ERG and PTEN status of isolated high-grade PIN occurring in cystoprostatectomy specimens without invasive prostatic adenocarcinoma

Carlos L. Morais, Liana B. Guedes, Jessica Hicks,

Human Pathology

2016

42

PTEN loss and ERG protein expression are infrequent in prostatic ductal adenocarcinomas and concurrent acinar carcinomas

Carlos L. Morais, Mehsati Herawi, Antoun Toubaji,

The Prostate

2015

41

In prostate cancer needle biopsies, detections of PTEN loss by fluorescence in situ hybridization (FISH) and by immunohistochemistry (IHC) are concordant and show consistent association with upgrading

Clarissa Gondim Picanço-Albuquerque, Carlos L. Morais, Filipe L.F. Carvalho,

Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin

2016

38

Analytic Validation of RNA <i>In Situ</i> Hybridization (RISH) for AR and AR-V7 Expression in Human Prostate Cancer

Liana B. Guedes, Carlos L. Morais, Fawaz Almutairi,

Clinical Cancer Research

2016

38

Page 1